(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...fits,"firstday"motionsbytheU.S.BankruptcyCourtfort...lastweekfiledavoluntarypetitionfor,reliefunderChap...ptcyCourt. , TheordersissuedbytheBankruptcyCo...uringtheChapter11proceedings.Inparticular,the,comp...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)...ewswire/--BlueMarbleEnergyCorp.announcedtodaythatt...DA)wererecentlyawarded$2millionbyWashingtonState,s...te/publicpartnershiptoconstructthestate,sfirstspec..., "Thisinvestmentwillsignificantlyspeedthedevelop...lnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wea...
(Date:11/24/2009)...pointhasbeenmetforpatientswithadvanced-stage,orrec...PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ: ...calcompanyfocusedonendocrinetherapyandoncology,tod...hitstargetedcytotoxicpeptideconjugate,AEZS-108(for...metrialcancer.Inapersonalizedhealthcareapproach,th...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4...ts Results for the First Three Months of 2008., C... today results for the three month period ended Ma...the following results:, Genmab,s revenues were DK...st quarter of 2008. In the same period of 2007, Ge.... USD 17 million)., An operating loss of DKK 197 ...
... The automation of,transaction-based processing is...n the United States. Foresight Corporation of Dubl...le of installations of Transaction,Insight(R) - th...., Transaction automation techniques enable healt...ficantly by integrating validation, error,reportin...
... DIEGO, May 28 Boston,Scientific Corporation (NYS...,announced that Boston Scientific has completed it...the definitive agreement announced on April 16.,Un...tstanding CryoCor,shares are entitled to receive $...ly $17.6 million. CryoCor is now an indirect, whol...
Other Biology Technology:Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4New Trend Sweeping Nation's Health Plans: Transaction Automation 2Boston Scientific Completes Acquisition of CryoCor 2Boston Scientific Completes Acquisition of CryoCor 3MBS Satellite Thermal Cycler from Thermo Scientific
...mates LC microfractionaction, spotting and prepara...LC eluent can be accurately and continuously spott... Matrix solutions can be added automatically. This... for MALDI-TOF-MS measurements. By using it in con...
CQCS kit for etra KR 4i from Thermo Scientific
...s a microprocessor controlled, high speed filter w...lly smooth operation make the Lambda 10-2 ideal fo...roscopy, ratio imaging, spectrophotometry, visual ... accurate aperture positioning. The Lambda 10-2 co...
Biology Products: